Abstract
Some pharmacological1,2 and neuroendocrinological3 data support the notion that in depression there is an increase in postsynaptic serotonin (5-hydroxytryptamine, 5-HT) receptor function consequent to a diminished presynaptic availability of 5-HT. Each of these lines of evidence has been criticized, and all are indirect. An alternative approach has been to examine parameters of serotonergic function in postmortem tissue. Studies to date have largely involved suicide cases. Conflicting results on 5-hydroxyindoleacetic acid (5-HIAA) levels and 5-HT receptors have been reported.4 Mann et al.5 reported a significant increase in the number of 5-HT sites in drug-free suicides compared with matched controls, but this was not replicated in another study.6 Such discrepancies may arise from the use of data from suicide patients, a heterogeneous group for whom clinical documentation is often lacking and of whom fewer than half may have a history of affective disorder.4
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Asberg M, Bertilsson L, Martenson B, et al. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984; 69: 201–219.
Van Praag HM. Management of depression with serotonin precursors. Biol Psychiatry 1981; 16: 290–310.
Meltzer HY, Umberkoman-Witta B, Robertson A, et al. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. Arch Gen Psychiatry 1984; 41: 366–374.
Ferrier IN, McKeith IG, Cross AJ, et al. Post-mortem neurochemical studies in depression. Ann NY Acad Sci 1986; 47: 128–142.
Mann JJ, Stanley M, McBride PA, et al. Increased serotonin and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986; 43: 954–959.
Owen FJ, Chambers DR, Cooper SJ, et al. Serotonergic mechanisms in brains of suicide victims. Brain Res 1986; 362: 185–188.
Nemeroff CB, Widerlov E, Bissette G, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226: 1342–1344.
Bissette G, Widerlov E, Walleus H, et al. Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in neuropsychiatric disorders. Arch Gen Psychiatry 1986; 43: 1148–1151.
McKeith IG, Marshall E, Ferrier IN, et al. 5HT receptor binding in post-mortem brain from patients with affective disorder. J Affective Disord 1987; 13: 67–74.
American Psychiatric Association. DSM III, Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: APA, 1980.
Linton E, Lowry PJ. Comparison of a specific two-site immunoradiometric assay with radioimmunoassay for rat/human CRF-41. Regul Peptides 1986; 14: 69–84.
Marcusson JO, Morgan DG, Winblad B, et al. Serotonin-2 binding sites in human frontal cortex and hippocampus: selective loss of S-2A sites with age. Brain Res 1984; 311: 51–56.
Bigeon A, Kargman S, Snyder L, et al. Characterisation and localisation of serotonin receptors in human brain post-mortem. Brain Res 1986; 353: 91–98.
Peroutka SJ, Snyder SH. Long term antidepressant treatment decreased spiperidol labelled serotonin receptor binding. Science 1980; 210: 88–90.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Ferrier, I.N. et al. (1989). Postmortem Investigation of Serotonergic and Peptidergic Hypotheses of Affective Illness. In: Lerer, B., Gershon, S. (eds) New Directions in Affective Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3524-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3524-8_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96769-1
Online ISBN: 978-1-4612-3524-8
eBook Packages: Springer Book Archive